Gastric Recalibration After Endoscopic Sleeve Gastroplasty
Trial Parameters
Brief Summary
Endoscopic sleeve gastroplasty (ESG) is a technique used for bariatric surgery, with results comparable to conventional surgery, in order to treat morbid obesity. It has also less risks of complications, and it is not an irreversible technique. It can be repeated overtime, regarding the evolution of the gastroplasty. There is little data in the literature on the effectiveness of endoscopic "revision". This study will assess the benefits and costs of a revision during the follow-up endoscopy.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 to 75 * Patients with morbid obesity (BMI≥ 30 with comorbidities or\> 40) * Patients with obesity for more than 2 years * Failure of medical treatment of obesity * Patients who may benefit from general anaesthesia * Patient able to participate in all aspects of the study and that agree to comply with all study requirements, for the duration of the study. This includes the availability of reliable transportation and sufficient time to attend all follow-up visits. * Patient able to fully understand the study and ready to give consent to participate to the study. * Patient affiliated to the French social security system Exclusion Criteria: * Patient with a contraindication to perform an ESG * Patient with a history of previous bariatric, gastric or esophageal surgery. * Patient who initiated medical therapy within the last 3 months, with evidence of weight gain. * Patient with an uncontrolled, poorly controlled, or suspected history of eating disorde